Your browser doesn't support javascript.
loading
Impact of the physical-chemical properties of poly(lactic acid)-poly(ethylene glycol) polymeric nanoparticles on biodistribution.
Jackman, Mark J; Li, Weimin; Smith, Aaron; Workman, David; Treacher, Kevin E; Corrigan, Adam; Abdulrazzaq, Fadi; Sonzini, Silvia; Nazir, Zahid; Lawrence, M Jayne; Mahmoudi, Najet; Cant, David; Counsell, Jonathan; Cairns, Jonathan; Ferguson, Doug; Lenz, Eva; Baquain, Saif; Madla, Christine M; van Pelt, Sally; Moss, Jennifer; Peter, Alison; Puri, Sanyogitta; Ashford, Marianne; Mazza, Mariarosa.
Afiliación
  • Jackman MJ; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, UK. Electronic address: mark.jackman1@astrazeneca.com.
  • Li W; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Smith A; DMPK, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Workman D; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Treacher KE; New Modalities & Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK.
  • Corrigan A; Data Sciences and Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Abdulrazzaq F; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Sonzini S; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Nazir Z; New Modalities & Parenteral Development, Pharmaceutical Technology & Development, Operations, AstraZeneca, Macclesfield, UK.
  • Lawrence MJ; Division of Pharmacy & Optometry and the North West Centre for Advanced Drug Delivery (NoWCADD), School of Health Sciences, University of Manchester, Manchester, UK.
  • Mahmoudi N; ISIS Pulsed Neutron and Muon Source, Rutherford Appleton Laboratory, Chilton, Didcot, UK.
  • Cant D; National Physical Laboratory, Teddington, UK.
  • Counsell J; Kratos Analytical, Wharfside, Manchester, UK.
  • Cairns J; Data Sciences and Quantitative Biology, Discovery Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Ferguson D; Drug Metabolism and Pharmacokinetics, Early Oncology Research and Development, AstraZeneca, Waltham, MA, USA.
  • Lenz E; Medicinal Chemistry, Research and Early Development, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Baquain S; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Madla CM; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, UK.
  • van Pelt S; Business, Planning & Operations, AstraZeneca, Cambridge, UK.
  • Moss J; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Peter A; Bioscience, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Puri S; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, UK.
  • Ashford M; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Macclesfield, UK.
  • Mazza M; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Cambridge, UK. Electronic address: mariarosa.mazza@astrazeneca.com.
J Control Release ; 365: 491-506, 2024 Jan.
Article en En | MEDLINE | ID: mdl-38030083
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Polietilenglicoles / Nanopartículas Límite: Animals Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2024 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Polietilenglicoles / Nanopartículas Límite: Animals Idioma: En Revista: J Control Release Asunto de la revista: FARMACOLOGIA Año: 2024 Tipo del documento: Article